SEC Form 4 · accession 0001144204-19-000514
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Mehren
Officer — PRESIDENT AND CEO · Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $11.50 | Jan 1, 2019 | A | 209,930 | A | — | Jan 1, 2029 | Common Stock | 209,930 | 209,930 | D |
| Employee Stock Option (right to buy)F3,F2 | $11.50 | Jan 1, 2019 | A | 37,736 | A | — | Jan 1, 2029 | Common Stock | 37,736 | 37,736 | D |
Explanation of responses
- F1The options vest in four (4) equal annual installments on each anniversary of the date of grant beginning on January 1, 2021.
- F2The options vest in twelve (12) equal monthly installments beginning on January 31, 2019.
- F3The options were issued to the reporting person under the 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (the "Sub-Plan") established pursuant to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan. Pursuant to the terms of the Sub-Plan, the reporting person irrevocably waived $125,000 of base compensation scheduled to be paid to the reporting person in 2019 in exchange for such options.